Prixa received funding of US$3 million from MDI Ventures and the Trans-Pacific Technology Fund.
Jakarta, TechnoBusiness ID (English Edition) • Prixa, a health technology company founded by James Roring in Jakarta in 2019, has secured new funding of US$3 million.
The new funding is planned to be used to expand the platform’s reach and user base as well as support Prixa’s B2B services.
In addition, it is also to increase accessibility to care services and digital transformation in the health sector in the country.
As a health technology platform, Prixa enables users to obtain artificial intelligence (AI)-based telemedicine and primary care services.
During the pandemic, Prixa’s performance grew exponentially, including in terms of drug delivery services and on-demand laboratory tests.
Roring, who also acts as CEO of Prixa, said that Prixa was built to facilitate access to health services through technology.
Seeing a potential opportunity, as a venture capitalist, together with MDI Ventures, Trans-Pacific Technology Fund is willing to disburse funding to Prixa.
“We see a significant opportunity to support the healthcare industry in Indonesia through cutting-edge technology,” said Barry Lee, Managing Director of Trans-Pacific Technology Fund.
Aditia Henri Narendra, GM Legal and Corporate Communication at MDI Ventures, also explained that Prixa has a proven track record in increasing patient satisfaction through telemedical services.•
—Vino Darmawan, TechnoBusiness ID • Photo: Prixa
Press the “bell button” on the left side of your screen to get notifications for the latest TechnoBusiness news faster.
Watch our news in video form on the TechnoBusiness TV channel. Don’t forget to give your attention by “like, comment, share, and subscribe”.